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OBJECTIVE—The hypothesis that high-fat (HF) feeding causes
skeletal muscle extracellular matrix (ECM) remodeling in C57BL/6J
mice and that this remodeling contributes to diet-induced muscle
insulin resistance (IR) through the collagen receptor integrin a2b1
was tested.
RESEARCH DESIGN AND METHODS—The association be-
tween IR and ECM remodeling was studied in mice fed chow or
HF diet. Speciﬁc genetic and pharmacological murine models
were used to study effects of HF feeding on ECM in the absence
of IR. The role of ECM-integrin interaction in IR was studied
using hyperinsulinemic-euglycemic clamps on integrin a2b1-null
(itga2
2/2), integrin a1b1-null (itga1
2/2), and wild-type littermate
mice fed chow or HF. Integrin a2b1 and integrin a1b1 signaling
pathways have opposing actions.
RESULTS—HF-fed mice had IR and increased muscle collagen
(Col) III and ColIV protein; the former was associated with
increased transcript, whereas the latter was associated with
reduced matrix metalloproteinase 9 activity. Rescue of muscle IR
by genetic muscle-speciﬁc mitochondria-targeted catalase over-
expression or by the phosphodiesterase 5a inhibitor, sildenaﬁl,
reversed HF feeding effects on ECM remodeling and increased
muscle vascularity. Collagen remained elevated in HF-fed itga2
2/2
mice. Nevertheless, muscle insulin action and vascularity were
increased. Muscle IR in HF-fed itga1
2/2 mice was unchanged.
Insulin sensitivity in chow-fed itga1
2/2 and itga2
2/2 mice was
not different from wild-type littermates.
CONCLUSIONS—ECM collagen expansion is tightly associated
with muscle IR. Studies with itga2
2/2 mice provide mechanistic in-
sight for this association by showing that the link between muscle
IR and increased collagen can be uncoupled by the absence of
collagen-integrin a2b1 interaction. Diabetes 60:416–426, 2011
T
he inﬂammatory response associated with in-
sulin resistance may have extensive effects on
extracellular matrix (ECM) remodeling and en-
dothelial cell function. ECM adaptations that
accompany insulin resistance in muscle are of great
potential signiﬁcance. Collagens, the most abundant struc-
tural components of ECM, not only support tissues but are
also required for cell adhesion and migration during
growth, differentiation, morphogenesis, and wound heal-
ing (1). Over 90% of the collagens expressed in skeletal
muscle are composed of collagen (Col) I, III, and IV. Al-
though ColI and ColIII comprise the ﬁbrillar-type collagen
(1), ColIV is the most abundant structural component of the
basement membrane (2,3). Seminal studies have shown that
insulin resistant human skeletal muscle is characterized by
increased collagen (4,5). However, the functional connec-
tion between insulin resistance and ECM expansion has
received little attention. Moreover, the mechanism(s) of
changes in collagens with insulin resistance is poorly de-
ﬁned.
Integrins are cell surface receptors that interact with
ECM and mediate both inside-out and outside-in signaling
(6,7). Of the 24 integrins identiﬁed in mammals, only four
of them bind collagens. These four collagen receptor
integrins share the b1-subunit, which heterodimerizes with
either the a1-, a2-, a10-, or a11-subunit (8). Previous studies
showed that activation of focal adhesion kinase, which is
downstream of integrin activation, was decreased in in-
sulin resistant skeletal muscle of high fat (HF)-fed rats (9).
Moreover, mice lacking integrin b1 expression speciﬁcally
in striated muscle develop insulin resistance (10). These
data suggest a role for collagen-integrin interaction in the
development of insulin resistance.
The two major collagen binding receptors, integrins
a1b1 and a2b1, are structurally similar but activate distinct
signaling pathways (11,12). Integrin a1b1 is antiﬁbrotic
since integrin a1-null mesangial cells show increased re-
active oxygen species (ROS) production and collagen
synthesis (13,14). In contrast, integrin a2b1 is proﬁbrotic
since activation of integrin a2b1 leads to increased ROS
production (15) and collagen expression (16,17). Integrins
a1b1 and a2b1 are both expressed on endothelial cells but
have opposing effects on endothelial cell biology. Integrin
a1b1 is proangiogenic, and its deletion leads to decreased
endothelial cell proliferation and angiogenesis in vivo
(18,19). In contrast, integrin a2b1 is antiangiogenic and its
deletion results in increased endothelial cell proliferation
and angiogenesis in vivo (20).
Herein we tested the hypothesis that the inﬂammatory
response associated with HF diet-induced insulin resis-
tance increases collagen in skeletal muscle of the mouse
and that this increase contributes to insulin resistance by
collagen receptor integrins a1b1 and a2b1. The speciﬁc
goals were to determine in HF-fed C57BL/6J mice whether
1) collagen accumulation in muscle occurs and the
mechanisms for any accumulation; 2) a pharmacological
or genetic manipulation that corrects muscle insulin
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ORIGINAL ARTICLEresistance of HF feeding eliminates collagen accumulation
and increases muscle vascularization; and 3) a genetic
deletion of integrin a2b1 protects against insulin resistance
and increases muscle vascularization, and a deletion of
integrin a1b1, which has actions that oppose integrin a2b1,
exacerbates insulin resistance.
RESEARCH DESIGN AND METHODS
Murine models. Mice were housed under temperature- and humidity-
controlled environment with a 12-h light/dark cycle. Distinctive murine models
were used to address speciﬁc goals of the study: 1) the association between
insulin resistance and ECM adaptations was studied in sex-matched C57BL/6J
mice fed chow or HF diet (F3282, BioServ) containing 60% calories as fat for
20 weeks; 2) novel genetic (muscle-speciﬁc mitochondrial-targeted catalase
transgenic, mcat
Tg) and pharmacological (sildenaﬁl) models were used to al-
leviate insulin resistance in the presence of HF feeding, and the rescue of the
ECM adaptations was assessed; and 3) integrin a1b1-null (itga1
2/2)a n da2b1-
null (itga2
2/2) mice were used to study the role of ECM-integrin interaction in
insulin resistance.
We previously showed that mcat
Tg mice maintained on a HF diet for 16
weeks were protected from insulin resistance (21). HF-fed mice treated with
subcutaneous injection of sildenaﬁl, a selective phosphodiesterase (PDE)5a
inhibitor, for 13 weeks are also protected from insulin resistance (22). The
mcat
Tg and sildenaﬁl-treated mice were selected as models that prevent diet-
induced muscle insulin resistance based on two considerations. First, these
approaches protect from diet-induced insulin resistance through speciﬁc
actions that target distinct mechanisms. The mcat
Tg mice selectively over-
express catalase in muscle mitochondria. It is a genetically modiﬁed animal
model in which the rescue of diet-induced muscle insulin resistance is related
to a reduction of mitochondrial release of ROS. This contrasts with the PDE5a
inhibition model, which causes smooth muscle relaxation and vasodilation
pharmacologically. The second consideration was that ROS have been impli-
cated in the regulation of collagen synthesis (13,23,24), and they do so by
increasing the inﬂammatory response and activation of mitogen-activated
protein kinase (MAPK) (25,26). Therefore, mcat
Tg mice provide a model for
studying the hypothesis that the inﬂammatory response associated with in-
sulin resistance increases collagen in muscle.
To further study the role of ECM-integrin interaction in insulin resistance,
mice lacking the two major collagen binding receptor integrins a1b1 or a2b1
were studied. Male itga2
2/2 mice and wild-type (WT) littermates (itga2
+/+)
were chow-fed until 9 weeks of age at which time mice were continued on
chow or switched to HF diet until 23 weeks of age. Male itga1
2/2 mice and WT
littermates (itga1
+/+) were chow-fed until 12 weeks of age at which time mice
were continued on chow or switched to HF diet until 28 weeks of age. Murine
body composition was determined by nuclear magnetic resonance. The Van-
derbilt Animal Care and Use Committee approved animal procedures.
Hyperinsulinemic-euglycemic clamp (insulin clamp). Catheters were
implanted in a carotid artery and a jugular vein of mice for sampling and
infusions 5 days before study (27). Insulin clamps were performed on 5-h
fasted mice (28). [3-
3H]glucose was primed (2.4 mCi) and continuously infused
for a 90-min equilibration period (0.04 mCi/min) and a 2-h clamp period (0.12
mCi/min). Baseline blood or plasma parameters were determined in blood
samples collected at 215 and 25 min. At t = 0, insulin infusion (4 mU/kg/min)
was started and continued for 165 min. Blood glucose was clamped at 150 ;160
mg/dL using a variable rate of glucose infusion (GIR). Mice received hepa-
rinized saline-washed erythrocytes from donors at 5 mL/min to prevent a fall of
hematocrit. Insulin clamps were validated by assessment of blood glucose
over time. Blood glucose was monitored every 10 min, and the GIR was ad-
justed as needed. Blood was taken at 80–120 min for the determination
of [3-
3H]glucose. Clamp insulin was determined at t = 100 and 120 min. At
120 min, 13 mCi of 2[
14C]deoxyglucose ([
14C]2DG) was administered as an
intravenous bolus. Blood was taken at 2–35 min for the determination of
[
14C]2DG. After the last sample, mice were anesthetized and tissues were
collected.
Insulin clamp plasma and tissue sample processing. Plasma insulin was




14C]2DG-6-phosphate were determined by liquid scintillation counting (22).
Glucose appearance (Ra) and disappearance (Rd) rates were determined using
non-steady-state equations (29). Endogenous glucose production (endoRa)
was determined by subtracting the GIR from total Ra. The glucose metabolic
index (Rg) was calculated as previously described (30).
Immunohistochemistry. ColI, ColIII, ColIV, and Von Willebrand factor (VWF)
were assessed by immunohistochemistry in parafﬁn-embedded tissue sections.
Sections (5 mm) were incubated with the following primary antibodies for 60
min: anti-ColI (Abcam), anti-ColIII (CosmoBio), anti-ColIV (Abcam), or anti-VWF
(DakoCytomation). Slides were lightly counterstained with Mayer hematoxylin.
The EnVision+HRP/DAB System (DakoCytomation) was used to produce lo-
calized, visible staining. Immunostaining of CD31 was performed in either frozen
sections or parafﬁn-embedded sections using anti-CD31 (BD Biosciences).
Images were captured using a Q-Imaging Micropublisher camera mounted on an
Olympus upright microscope. Immunostaining was quantiﬁed by ImageJ or
BIOQUANT Life Science 2009. ColI, ColIII, and ColIV protein were measured by
the integrated intensity of staining. Muscle vascularity was determined by
counting CD31-positive structures and by measuring areas of VWF-positive
structures.
Real-time PCRs. Total RNA was isolatedfromgastrocnemius using the RNeasy
Fibrous Tissue Kit (Qiagen). Total RNA (1 mg) was reverse transcribed using the
iScript cDNA Synthesis Kit (Bio-Rad). Real-time PCR was then performed using
the SYBR Green JumpStart Taq Readymix (Sigma) on an IQ5 Multicolor Real-
Time PCR Detection System (Bio-Rad). The primers used are listed in
Supplementary Table 1. Data were analyzed by the 2
2DDCt method (31).
Gelatin zymography. Gelatin zymography was performed to measure the
activities of type IV collagenase-matrix metalloproteinase (MMP)2 and MMP9
(32). Gastrocnemius was homogenized in buffer containing 0.5% Triton X-100,
100 mM Tris-HCl, 10 mM EDTA, and 10 mL/mL protease inhibitor (pH 7.5).
Homogenates were centrifuged at 13,000 rpm for 20 min at 4°C. The super-
natant (500 mg) was incubated at 4°C for 2 h with 40 mL of gelatin-Sepharose
(Pharmacia). After the incubation, the gelatin-Sepharose beads were resus-
pended in nonreducing SDS-sample buffer and loaded on 10% zymogram gels
(Invitrogen). The gel was developed according to the manufacturer’si n s t r u c -
tions. Conditioned medium from HT-1080 cells was used as positive control.
Western blotting. Gastrocnemius was homogenized in buffer containing
50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton
X-100, 1 mM DTT, 1 mM PMSF, 5 mg/mL protease inhibitor, 50 mM NaF, and
5 mM sodium pyrophosphate and centrifuged at 13,000 rpm for 20 min at 4°C.
The supernatant (40 mg) was applied to 4–12% SDS-PAGE gel. Phosphorylated
and total Akt/protein kinase B (PKB) were probed using phospho-Akt(Ser473)
and Akt antibodies (Cell Signaling). Phosphorylated and total insulin receptor
substrate-1 (IRS-1) were probed using phospho–IRS-1 (Tyr612) and IRS-1 anti-
bodies (Upstate).
Statistical analysis. Data are expressed as means 6 SE. Statistical analyses
were performed using Student t test or two-way ANOVA followed by Turkey
post hoc tests as appropriate. The signiﬁcance level was P , 0.05.
RESULTS
Diet-induced insulin resistance increases skeletal
muscle collagen expression. Twenty weeks of HF diet
in C57BL/6J mice, a regimen that induces insulin re-
sistance (33), caused inﬂammation in muscle, as gene ex-
pression of F4/80, a macrophage marker, and TNF-a,a
cytokine involved in systemic inﬂammation, was increased
in muscle of HF-fed mice compared with chow-fed mice
(Fig. 2A and B). To test the hypothesis that the inﬂam-
matory response associated with diet-induced insulin re-
sistance in mice is accompanied by increased muscle
collagen, we measured collagen expression in HF-fed mu-
rine muscle. Muscle ColIII and ColIV protein were increased
in HF-fed mice compared with chow-fed mice (Fig. 1A), but
protein expression of ColI was very low and differences
were undetectable.
Increases in collagen could be because of either increased
synthesis or decreased degradation via MMPs. mRNA of
speciﬁc collagen chains were used to assess collagen syn-
thesis. HF feeding increased muscle mRNA of ColIa1,
ColIa2, and ColIIIa1 chains, whereas mRNA of ColIV was
unchanged (Fig. 1B). To test whether increased ColIV pro-
tein was due to reduced degradation, the activities of type IV
collagenases, MMP2 and MMP9, were measured. HF feeding
decreased MMP9 activity, without affecting pro-MMP2 and
MMP2 activities in muscle (Fig. 1C).
Genetic and pharmacological rescue of skeletal
muscle insulin resistance after HF feeding decreases
muscle inﬂammation and collagen expression and
improves muscle vascularization. Muscle insulin re-
sistance was absent in HF-fed mcat
Tg (21) and sildenaﬁl-
treated mice (22). In line with decreased muscle insulin
L. KANG AND ASSOCIATES
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Tg and sildenaﬁl-treated mice had
reduced F4/80 expression in muscle (Fig. 2A and C). HF
diet-induced increase in muscle TNF-a mRNA was also
eliminated in mcat
Tg mice (Fig. 2B); although, the decrease
in TNF-a mRNA in muscle of sildenaﬁl-treated mice was
nearly 50%, the measurements in WT were variable and
differences were not signiﬁcant (Fig. 2D). ColIII and
ColIV proteins were decreased in mcat
Tg and sildenaﬁl-
treated mice (Fig. 2E). The lower expression of ColIII
in HF-fed mcat
Tg mice was because of reduced synthesis,
as the HF-induced increases in mRNA of ColIIIa1 were
abolished (Fig. 3B). HF-induced increase in mRNA of
ColIa2 was also abolished in mcat
Tg mice (Fig. 3A). De-
creased ColIV protein was due at least in part to increased
degradation via MMP9 as MMP9 activity was increased
in muscle of HF-fed mcat
Tg and sildenaﬁl-treated mice
(Fig. 3C).
Decreased collagen deposition in HF-fed mcat
Tg and
sildenaﬁl-treated mice was associated with improved
muscle vascularization, since blood vessel staining by
CD31 and VWF was increased (Fig. 3D). Taken together,
preventing diet-induced muscle insulin resistance using
different approaches that focus on distinct targets results
in common ECM adaptations. These common adaptations
FIG. 1. HF feeding to C57BL/6J mice increased muscle collagen expression. A: Immunohistochemical detection of ColIII and ColIV proteins in
gastrocnemius of chow-fed and HF-fed C57BL/6J mice. The magniﬁcation of images was 203. B: mRNA levels of ColIa1, ColIa2, ColIIIa1, and
ColIVa1. C: Gelatin zymogram of protein extracts from gastrocnemius of mice after either chow or HF feeding for 20 weeks. The white bands
indicate the presence of type IV collagenase activity, MMP-9, pro-MMP2, and MMP2. Data are represented as means 6 SE; n =4;7. *P < 0.05 chow
vs. HF. (A high-quality color representation of this ﬁgure is available in the online issue.)
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increased vascularization.
Genetic deletion of integrin a2b1 diminishes skeletal
muscle insulin resistance associated with HF feeding.
Integrins a1b1 and a2b1 are collagen receptors expressed
on the endothelial cell surface (19,20), as well as on sev-
eral other cell types (8). To test the role of ECM-integrin
signaling in the pathogenesis of insulin resistance, we
assessed insulin action in chow and HF-fed itga1
2/2 and
itga2
2/2 mice using insulin clamps. HF feeding increased
body weight, body fat, and basal 5-h fasting glucose and
insulin levels in all genotypes (Table 1). Body weights and
body fat were not different between null mice and their
respective WT littermates either on chow or HF diet. Basal
5-h fasting blood glucose did not differ between itga1
+/+
and itga1
2/2 mice regardless of diet; however, the basal
5-h fasting blood glucose was lower in the HF-fed itga2
2/2
mice compared with HF-fed itga2
+/+ mice. Blood glucose
was maintained at 150 ;160 mg/dL during the insulin
clamp in all groups (Table 1 and Fig. 4A, D, G, and J).
Plasma insulin was not different between null mice and
their respective WT littermates either in basal or insulin-
clamped state within a speciﬁc diet (Table 1).
In chow-fed mice, GIR during the insulin clamp were not
different between itga1
2/2 and itga1
+/+ mice or itga2
2/2
and itga2
+/+ mice (Fig. 4B and E). Rg in muscle was also not
affected by genotype (Fig. 4C and F). HF feeding induced
insulin resistance in all groups as shown that GIR and Rg
were dramatically decreased by HF feeding (Fig. 4B, C, E,
and F vs. 4H, I, K,a n dL). In contrast with chow-fed mice,
GIR was lower in the HF-fed itga1
2/2 mice compared with
HF-fed itga1
+/+ mice (Fig. 4H) but higher in the HF-fed
itga2
2/2 mice when compared with HF-fed itga2
+/+ mice
(Fig. 4K). Muscle Rg was not different between HF-fed
itga1
2/2 and itga1
+/+ mice (Fig. 4I). However, muscle Rg was




Because integrins a1b1 and a2b1 are expressed in a cell
type that is widely distributed (i.e., endothelial cells), the
metabolic phenotype of HF-fed null mice is not necessarily
FIG. 2. Rescue of muscle inﬂammation and collagen expansion by catalase overexpression and chronic treatment with sildenaﬁl. A–D: Muscle
inﬂammation was assessed by measuring the mRNA levels of F4/80 and TNF-a using the quantitative real-time PCR. E: Immunohistochemical
detection of ColIII and ColIV proteins in gastrocnemius of mice. The magniﬁcation of images was 203. Values represent means 6 SE of integrated
intensity of staining for ColIII and ColIV. Data are normalized to WT HF or vehicle HF, and n is equal to 4 for the WT and mcat
Tg mice, 6 ;8 for the
vehicle- and sildenaﬁl-treated mice. #P < 0.05 compared with WT chow. *P < 0.05 compared with WT HF or vehicle HF. (A high-quality color
representation of this ﬁgure is available in the online issue.)
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tion in liver and adipose tissue, two other insulin-sensitive
glucoregulatory organs, in HF-fed integrin null mice and
WT littermates. Basal endoRa was not different between
HF-fed itga1
2/2 and itga1
+/+ mice (Fig. 5A). Insulin in-
fusion decreased endoRa by 50% in the HF-fed itga1
+/+ mice.
In contrast, endoRa was not suppressed in the itga1
2/2
mice. These data are consistent with the lower GIR and
reﬂects greater hepatic insulin resistance in HF-fed itga1
2/2
mice. Rd was not different between the HF-fed itga1
2/2
and itga1
+/+ mice either in basal or insulin-clamped state
(Fig. 5B). Insulin-stimulated adipose tissue Rg was de-
creased in HF-fed itga1
2/2 mice relative to itga1
+/+ mice
(Fig. 5C). Rd was not reduced since white adipose tissue is
a small contributor to total glucose disposal. EndoRa was
not different between the itga2
2/2 mice and the itga2
+/+ mice
either in basal or insulin-clamped state (Fig. 5D); however,
Rd during the insulin clamp was higher in itga2
2/2 com-
pared with itga2
+/+ (Fig. 5E). This is consistent with in-
creased Rg in muscles. Adipose tissue Rg did not differ
between HF-fed itga2
2/2 and itga2
+/+ mice (Fig. 5F).
These data suggest that the HF-fed itga1
2/2 mice have
a further impairment in hepatic and adipose insulin re-
sistance with no impairment in muscle insulin resistance.
HF-fed itga2
2/2 mice have improved insulin sensitivity
because of decreased muscle insulin resistance.
Changes in muscle insulin signaling after the clamp were
consistent with ﬂux measurements observed during the
clamp in HF-fed itga2
2/2 mice. Phosphorylation of IRS-1
and Akt were increased in muscle of HF-fed itga2
2/2 mice
compared with those of the itga2
+/+ littermates, indicative
of improved insulin signaling (Fig. 6A and B). There was
no effect on total Akt and IRS-1 in HF-fed itga2
2/2 mice.
Decreased skeletal muscle insulin resistance in HF-fed
itga2
2/2 mice was associated with unchanged collagen
expression and increased muscle vascularization. In
contrast with our ﬁndings in mcat
Tg and sildenaﬁl-treated
mice, the HF-fed itga2
2/2 mice were protected against
HF-induced muscle insulin resistance despite no re-
duction in muscle ColIII and ColIV proteins (Fig. 6C).
FIG. 3. Catalase overexpression and chronic treatment with sildenaﬁl rescued muscle ECM adaptation and improved muscle vascularization. A and
B: mRNA levels of ColIa2 and ColIIIa1 in gastrocnemius of WT and mcat
Tg mice. C: Gelatin zymogram of protein extracts from gastrocnemius of
mice. MMP2 was not detectable in muscle under current experimental conditions. Arbitrary density of the MMP9 bands was listed. D: Immuno-
histochemical detection of vascular markers, CD31 and VWF. The magniﬁcation of images was 203. Representative images are presented. Values
represent means 6 SE of numbers of CD31-positive structures or of areas occupied by VWF-positive structures. Data are normalized to WT HF or
vehicle HF, and n is equal to 4 for the WT and mcat
Tg mice, 6 ;8 for the vehicle- and sildenaﬁl-treated mice. #P < 0.05 compared with WT chow.
*P < 0.05 compared with WT HF or vehicle HF. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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CD31 and VWF was increased in muscle of HF-fed itga2
2/2
compared with HF-fed itga2
+/+ mice (Fig. 6C). This is
consistent with results obtained in mcat
Tg and sildenaﬁl-
treated mice. These data provide further evidence for the
association between increased muscle insulin sensitivity
and vascularization.
DISCUSSION
Our studies show that HF-fed insulin-resistant mice are
characterized by an increase in muscle collagen. It is im-
portant to recognize that this is not a response that is
isolated to this murine model, but is an established char-
acteristic of human insulin resistant muscle (4,5). Thus the
study of collagen and ECM in HF-fed mouse has great
relevance to the human condition. By the use of geneti-
cally modiﬁed and sildenaﬁl-treated mice, the current
study demonstrates a close association between collagen
dynamics and the pathogenesis of muscle insulin re-
sistance. Furthermore, studies in itga2
2/2 mice provide
mechanistic insight for this association by showing that
the link between muscle insulin resistance and increased
collagen is uncoupled in the absence of collagen-integrin
a2b1 interaction.
Inﬂammation can cause insulin resistance (34), and
collagen deposition and ECM remodeling are hallmarks of
inﬂammation (2). Here we tested the hypothesis that the
inﬂammatory response associated with a HF diet would
increase collagen, causing a formidable barrier to muscle
glucose uptake and affecting muscle vascular reactivity
(Fig. 7). In the current study, overexpression of catalase
in the mitochondria, which reduces oxygen free radical
production, prevented muscle inﬂammation, diminished
collagen expansion, improved vascularity, and rescued
insulin resistance. It is known that PDE5a inhibition
increases vascular reactivity. PDE5a inhibition prevented
collagen expansion by decreasing the inﬂammatory re-
sponse. PDE5a inhibition, like catalase overexpression,
rescued insulin resistance. Integrin a2b1 is expressed in
endothelial cells (8), and loss of integrin a2b1 leads to
increased endothelial cell proliferation and angiogeneis in
vivo (20). Endothelial/vascular dysfunction is associated
with insulin resistance (35). Here we found that enhanced
muscle insulin action in mice lacking the integrin a2b1
receptor was also associated with increased angiogenesis.
We postulate that the lack of an adaptive increase in vas-
cularization and endothelial function contributes to diet-
induced insulin resistance in C57BL/6J mice. Murine
models that are able to adapt in this way have diminished
insulin resistance.
TNF-a, a cytokine involved in systemic inﬂammation,
has been shown to regulate collagen expression (36,37). In
line with decreased muscle inﬂammation and collagen
expression, mcat
Tg mice also had decreased muscle TNF-a
gene expression. These data suggest that inﬂammation
increases collagen expression possibly mediated via TNF-a.
Although TNF-a mRNA tended to be reduced in HF-fed
sildenaﬁl-treated mice when compared with the HF-fed
control mice, differences were not signiﬁcant. This suggests
that factors other than TNF-a c o u l da l s op l a yar o l ei n
inﬂammation-mediated collagen regulation.
We showed that the increases in muscle collagen were
corrected when muscle insulin resistance was rescued
either by genetic manipulation (mcat
Tg) or pharmacologi-
cal treatment (sildenaﬁl). It is important to note that these
two models improve muscle insulin sensitivity and sup-
press the diet-induced increases in ColIII and ColIV, by
distinct primary mechanisms. mcat
Tg reduces mitochon-
drial release of ROS (21), whereas chronic treatment with
sildenaﬁl inhibits PDE5a, causing an induction of smooth
muscle relaxation and vasodilation (22). Thus, despite
targeting different initial pathways within skeletal muscle,
both models reverse excess collagen deposition in response
to HF feeding. Bajaj et al. (38) showed that a sustained
reduction in plasma free fatty acids in insulin-resistant
relatives of patients with type 2 diabetes leads to an in-
crease in insulin sensitivity, but paradoxically increases
mRNA for ECM proteins. Differences in the experimental
paradigm make it difﬁcult to compare those results with
ﬁndings from the current study and previous studies in
humans from the same laboratory (4). Whether this para-
doxical increase in collagen gene expression observed in
the study of Bajaj et al. is paralleled by an increase in pro-
tein was not assessed. Acipimox, a nicotinic acid analog that
activates Gi protein-coupled receptors (39), was used to
lower free fatty acids in the study of Bajaj et al. It is possible
that acipimox affects collagen mRNAs independent of
effects on insulin action. It is clear that the association be-
tween ECM remodeling, free fatty acids, and insulin resis-
tance is complex and remains to be fully deﬁned.
TABLE 1
Characteristics of the integrin deﬁcient mice
a1b1 a2b1











Weight (g) 29 6 12 8 6 14 6 6 14 5 6 12 7 6 12 8 6 14 9 6 24 8 6 1
Body fat (%) 9 6 18 6 13 8 6 14 1 6 16 6 16 6 24 1 6 14 0 6 1
Age at study (weeks) 28 28 28 28 23 23 23 23
Duration on HF (weeks) ——16 16 ——14 14
Blood glucose (mg/dL)
Basal 129 6 5 124 6 2 166 6 9 167 6 8 137 6 3 137 6 1 190 6 3 154 6 5*
Clamp 149 6 3 146 6 2 153 6 3 153 6 2 152 6 3 153 6 17 156 6 2 157 6 4
Plasma insulin (ng/mL)
Basal 1.5 6 0.2 1.4 6 0.1 7.2 6 1.5 6.6 6 1.1 0.7 6 0.2 0.8 6 0.3 9.6 6 1.6 11.7 6 1.2
Clamp 6.0 6 0.6 4.6 6 0.5 9.5 6 0.8 8.9 6 1.4 3.8 6 0.7 4.6 6 0.7 11.7 6 1.2 14.0 6 0.5
Data are expressed as means 6 SE. *P , 0.05 itga2
2/2 HF vs. itga2
+/+ HF.
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the hyperinsulinemic-euglycemic clamp. A, D, G, and J: Blood glucose was maintained at 150 ;160 mg/dL in all groups of mice. Time course is
presented to illustrate the quality of the clamps. B, E, H, and K: To maintain this euglycemia, 50% glucose was infused into mice throughout the
clamp. C, F, I,a n dL: Nonmetabolizable glucose analog [
14C]2-deoxyglucose was administered as an intravenous bolus to determine the glucose
uptake (Rg) in muscles. Values represent means 6 SE, n =3;7 for each group. *P < 0.05 compared with itga1
+/+ HF or itga2
+/+ HF. SVL, superﬁcial
vastus literalis.
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resistance (9,10). Because the two major collagen binding
receptors integrin a1b1 and a2b1 have been implicated in
inﬂammation (40) and angiogenesis (18,20), as well as
collagen synthesis (14,16), we used mice selectively lack-
ing integrin a1b1 or a2b1 to examine the role of collagen-
integrin interaction in the development of insulin resistance.
Consistent with our hypothesis, insulin resistance was
exacerbated in HF-fed itga1
2/2 mice because of further
impairments in hepatic and adipose insulin resistance.
Muscle insulin resistance in HF-fed itga1
2/2 mice was not
further impaired, possibly because of an already high re-
sistance in muscle. In contrast with integrin a1b1, deletion
of integrin a2b1 protected against muscle insulin resistance
induced by HF feeding. Integrin a2b1 is shown to be a pos-
itive regulator of collagen expression when cultured cells
expressing a2b1 grow in three-dimensional collagen gel
(16,17). However, we found no changes in muscle collagen
expression in HF-fed itga2
2/2 mice. This disparity could be
because of differences in models and/or cell types studied.
Conversely muscle vascularization was increased, which
we hypothesize contributes to decreased HF-induced mus-
cle insulin resistance in itga2
2/2 mice. This observation is
consistent with the antiangiogenic nature of integrin a2b1
(20). The fact that deletion of integrin a2b1 improves diet-
induced muscle insulin resistance without a reduction in
muscle collagen suggests that ECM collagen expansion
is associated with muscle insulin resistance by interaction
with integrin a2b1.
Although deletion of integrin a2b1 improves HF-induced
muscle insulin resistance, as shown by an approximate
fourfold increase in Rg, muscle insulin sensitivity in the
HF-fed itga2
2/2 mice is still below that seen in chow-fed
itga2
+/+. This suggests that although the collagen-integrin
a2b1 interaction is an important determinant of insulin
resistance it, not surprisingly, is just one piece of the insulin
resistance syndrome. Deletion of the integrin b1-subunit
speciﬁcally in striated muscle results in insulin resistance
in chow-fed mice (10). It is possible that a-subunits other
than a1 and a2, which dimerize with the integrin b1-subunit,
may also contribute to insulin resistance. ColIII and ColIV
protein was increased in muscle of HF-fed mice. It is also
possible that the expanded collagens increase the spatial
barrier and the nature of the physical barrier from blood to
muscle, thus contributing to insulin resistance. In contrast
with ColIII and ColIV, protein expression of ColI was very
FIG. 5. Insulin sensitivity in liver and adipose tissue of HF-fed integrin a1- and integrin a2-null mice during the hyperinsulinemic-euglycemic clamp.
A and D: Endogenous glucose production (endoRa) was calculated by subtracting the glucose infusion rate from total Ra. B and E: Glucose dis-
appearance rate (Rd) was determined using non-steady-state equations. C and F: Nonmetabolizable glucose analog [
14C]2-deoxyglucose was ad-
ministered as an intravenous bolus to determine the glucose uptake (Rg) in adipose tissue. Values represent means 6 SE; n =5;6 for each group.
For A, B, D,a n dE,* P < 0.05 compared with itga1
+/+ HF at basal or itga2
+/+ HF at basal. For C,* P < 0.05 compared with itga1
+/+ HF.
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rier. However, the mRNA levels of both ColIa1a n dC o l I a2
were increased in muscle of HF-fed mice, implying that
ColI remodeling could also be a part of insulin resistance.
The interaction between ColI and integrins even at a very
low level could conceivably impact cell signaling. There is
the potential for interaction between the ECM and many
cell surface receptors besides integrins, such as discoidin
domain and growth factor receptors (41). These inter-
actions could produce chemical or mechanical signal
transduction changes that have impact on intracellular
pathways.
These data obtained in murine models extend studies
conducted in human subjects, which have shown that
insulin-resistant humans have increased muscle collagen
(4,5). We show for the ﬁr s tt i m et h a td i s t i n c tg e n e t i ca n d
pharmacological murine models that correct insulin re-
sistance prevent the accumulation of collagen in skeletal
muscle and exhibit increased muscle vascularity.
Through the use of itga2
2/2 mice we provide mechanistic
insight into this association by showing that the link be-
tween muscle insulin resistance and increased collagen is
uncoupled in the absence of integrin a2b1. The deletion of
integrin a2b1 also promotes increased vascularization in
muscle. The results support the concept that increased
collagen contributes to insulin resistance through interac-
tion with endothelial integrin a2b1 protein. Therefore, our
ﬁndings demonstrate novel roles of ECM expansion in the
pathogenesis of insulin resistance. Manipulations that limit
ECM expansion or target integrin signaling may provide
new opportunities to explore therapeutics for insulin re-
sistance and type 2 diabetes.
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FIG. 6. Insulin signaling, collagen expression, and vascularization in gastrocnemius muscle of HF-fed itga2
+/+ and itga2
2/2 mice. A and B: Tissue
homogenates extracted from gastrocnemius were applied to 4–12% SDS-PAGE gel. Western blotting was then performed using the antiphospho-
Akt or antiphospho-IRS-1. Values are expressed as means 6 SE of integrated intensity, and representative bands are presented; n =5;6. *P < 0.05
compared with itga2
+/+ HF. C: Parafﬁn-embedded tissue sections were stained with anti-ColIII, anti-ColIV, or anti-VWF antibodies. Frozen tissue
sections were stained with anti-CD31 antibody. The magniﬁcation of images was 203. Data are expressed as means 6 SE of integrated intensity of
staining for ColIII and ColIV, or of numbers of CD31-positive structures, or of areas occupied with VWF-positive structures in each section.
Representative images are presented; N is equal to 6 for the itga2
+/+ HF group and 3 ;6 for the itga2
2/2 HF group. *P < 0.05 itga2
2/2 HF vs. itga2
+/+
HF. (A high-quality color representation of this ﬁgure is available in the online issue.)
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